American International Group Inc. Sells 1,948 Shares of HealthEquity, Inc. (NASDAQ:HQY)

American International Group Inc. cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 154,813 shares of the company’s stock after selling 1,948 shares during the quarter. American International Group Inc. owned approximately 0.18% of HealthEquity worth $12,637,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of HQY. Motley Fool Asset Management LLC boosted its holdings in HealthEquity by 3,001.0% during the 1st quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after acquiring an additional 3,640,748 shares during the period. Mackenzie Financial Corp boosted its holdings in HealthEquity by 58.2% during the 4th quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after acquiring an additional 664,979 shares during the period. Norges Bank purchased a new stake in HealthEquity during the 4th quarter valued at about $43,482,000. Vaughan Nelson Investment Management L.P. purchased a new stake in HealthEquity during the 1st quarter valued at about $49,443,000. Finally, Wasatch Advisors LP boosted its holdings in HealthEquity by 8.3% during the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HQY has been the subject of several analyst reports. JPMorgan Chase & Co. increased their target price on HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a report on Tuesday, April 2nd. Wells Fargo & Company lifted their price objective on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research report on Thursday, June 20th. Robert W. Baird lifted their price objective on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research report on Tuesday, June 4th. Finally, JMP Securities lifted their price objective on HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.67.

HealthEquity Stock Up 2.6 %

Shares of NASDAQ HQY traded up $2.04 during mid-day trading on Thursday, hitting $80.20. 278,837 shares of the stock traded hands, compared to its average volume of 618,636. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. HealthEquity, Inc. has a 52 week low of $61.50 and a 52 week high of $88.26. The company has a market cap of $6.98 billion, a price-to-earnings ratio of 84.96, a PEG ratio of 1.33 and a beta of 0.57. The stock has a fifty day moving average price of $81.39 and a 200-day moving average price of $79.85.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.08. The company had revenue of $287.60 million for the quarter, compared to analyst estimates of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. Research analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of HealthEquity stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares in the company, valued at $19,231,138.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the transaction, the director now owns 6,070 shares in the company, valued at $497,072.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,511 shares of company stock worth $3,519,346. 2.20% of the stock is owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.